Report overview
This report contains market size and forecasts of Silver Sulfadiazine API in global, including the following market information:
Global Silver Sulfadiazine API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Silver Sulfadiazine API Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Silver Sulfadiazine API companies in 2022 (%)
The global Silver Sulfadiazine API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Purity Above 99% Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Silver Sulfadiazine API include Macsen Drugs, Lusochimica SpA, India Phosphate, Amishi Drugs & Chemicals, Teva Pharmaceutical Industries, Lek Pharmaceuticals dd, Chengdu Shidai No.1 Pharmaceutical, Henan Quanyu Pharmaceutical and Hunan Er-Kang Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Silver Sulfadiazine API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Silver Sulfadiazine API Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Silver Sulfadiazine API Market Segment Percentages, by Type, 2022 (%)
Purity Above 99%
Purity Below 99%
Global Silver Sulfadiazine API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Silver Sulfadiazine API Market Segment Percentages, by Application, 2022 (%)
Ointment
Others
Global Silver Sulfadiazine API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Silver Sulfadiazine API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Silver Sulfadiazine API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Silver Sulfadiazine API revenues share in global market, 2022 (%)
Key companies Silver Sulfadiazine API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Silver Sulfadiazine API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Macsen Drugs
Lusochimica SpA
India Phosphate
Amishi Drugs & Chemicals
Teva Pharmaceutical Industries
Lek Pharmaceuticals dd
Chengdu Shidai No.1 Pharmaceutical
Henan Quanyu Pharmaceutical
Hunan Er-Kang Pharmaceutical
Lianyungang Runzhong Pharmaceutical
Suzhou Homesun Pharmaceutical
Northeast Pharmaceutical Group
Shenyang Funing Pharmaceuticals
Beijing Jingfeng Pharmaceutical (Shandong)
